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| Chapter 1
In the early sixties the world was shocked by the thalidomide (Softenon) “epidemic”. This 
drug, used as a sedative and in treatment of nausea in pregnant women, resulted in births 
of infants affected by severe congenital anomalies such as limb reduction defects 1-3. In 
the late sixties, Vietnamese citizens and Vietnam War veterans reported increased rates 
of congenital anomalies in their offspring after exposure to Agent Orange, an herbicide 
used to destroy dense jungle get advance of the Vietnamese guerrillas during the war 4. 
In 2015, the Zika virus spread rapidly throughout South America and led to an increased 
number of infants born with microcephaly in Brazil 5. Recently, possible new congenital 
anomaly “epidemics” were reported in the media, such as an increased prevalence of 
congenital anomalies in Limburg, the Netherlands 6, three infants born with deformed 
hands in Germany 7, and increased rates of limb reduction defects in France 8. Despite wide-
spread rumours regarding the causes of those increases in the numbers of infants born 
with congenital anomalies, no scientific evidence for a true increase and no specific cause 
have been identified as of yet 9. These events emphasize the need for congenital anomaly 
registries and systematic epidemiological research. Through monitoring of the prevalence 
of congenital anomalies, the true increases in congenital anomalies and potential risk 
factors for rare and specific congenital anomalies can be studied.
CONGENITAL ANOMALIES
Worldwide, congenital anomalies are one of the main causes of neonatal and infant 
mortality 10-12. One in 33 infants is affected by a congenital anomaly, resulting in more than 
100,000 affected births in Europe each year. The majority of these births result in live-born 
infants, about 2% are stillbirths, and around 20% of the pregnancies are terminated because 
of a congenital anomaly (EUROCAT 2011-2017)13. If new-borns survive, they often have 
to deal with long-term disabilities or need surgery. Depending on the type of anomaly, 
this could be one relatively simple surgical intervention or several complex interventions. 
This not only impacts the life of the child, but also their families, healthcare systems and 
society. In this thesis, congenital anomalies are defined as anomalies that develop during 
intrauterine life. In Figure 1 the distribution of the different types of congenital anomalies 
are displayed. The most common congenital anomalies are congenital heart defects (30%), 
followed by chromosomal disorders (17%), limb anomalies (17%) and urinary anomalies 
(14%).




Figure 1 | Distribution of anomaly groups: Eurocat – Prevalence 2011-2017 13
RISK FACTORS
Congenital anomalies can be caused by genetic factors, environmental factors, or a 
combination of both. Primary foetal development and organogenesis starts directly after 
conception (Box 1). Since the foetus is vulnerable during this process, external exposures 
during the periconceptional period (one month before conception through three months 
after conception) can affect embryological development. Maternal medical conditions 
that can increase the risk of congenital anomalies are being overweight, having poorly 
regulated maternal diabetes, phenylketonuria, and infections during the periconceptional 
period (e.g. cytomegalovirus, rubella, and Zika virus) 14-16. In addition, the use of specific 
drugs such as anticonvulsants, antidepressants, cholesterol-lowering agents, angiotensin-
converting enzyme inhibitors, and folic acid antagonists may result in an increased risk of 
congenital anomalies 15,17. On the other hand, pregnant women and women who want to 
become pregnant are advised to take folic acid supplementation starting four weeks prior 
to conception through 10 weeks after conception because folic acid supplementation 
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reduces the risk of neural tube defects and congenital heart defects 18,19. Several lifestyle 
factors can also increase the risk of congenital anomalies in offspring, including maternal 
and paternal smoking, alcohol consumption, and illicit drug use 15,20,21. In the general 
environment women can be exposed to air pollutants that can increase the risk of 
congenital anomalies 22. Exposures to teratogens can also occur in the workplace and 
could be an important risk factor for congenital anomalies.
Box 1 - The critical time after conception (Embryology)
After the oocyte is fertilized by the spermatozoa, the zygote is formed. The zygote 
undergoes cleavage, which results in the blastula (day 5 after conception). This 
blastula (1.5-2.0 mm) implants in the endometrium of the uterus and undergoes 
gastrulation (day 7). This process results in the formation of three germ layers: 
mesoderm, ectoderm, and endoderm. Each of these germ layers differentiates into 
different organ systems. Three weeks after conception, body folding starts, and the 
embryo will have a shape that is starting to resemble that of the adult. At the same 
time, organogenesis takes place and limbs develop. The ectoderm forms the nervous 
system and skin cells, the mesoderm gives rise to the muscle cells and connective 
tissue in the body, and the endoderm forms the digestive system and other internal 
organs. The heart begins to beat at week 4, and the primary organs are formed 8 
weeks after conception 67.
OCCUPATIONAL EXPOSURE
As an increasing number of women are working during their reproductive years, knowledge 
about occupational risk factors is important for employers and employees, as well as 
freelancers and independent contractors. Nowadays, more than 80% of Dutch women 
are participating in the labour force, compared to just 50% 40 years ago 23. Although Dutch 
women work fewer hours than women anywhere else in Europe, the number of hours 
women are working in the Netherlands is increasing over time 24,25.
During their work, women can be exposed to a wide range of factors that might affect 
their reproductive health and pregnancy outcomes. Exposure to various chemicals, such 
as solvents, pesticides and metals, have been associated with reduced fertility, prolonged 




time to pregnancy, increased risks of spontaneous abortions, prematurity, and reduced 
birth weight 26-29. A variety of occupational exposures are discussed in this thesis: mineral 
dust, biological dust, gases and fumes, and more specific solvents, pesticides, metals, 
and other endocrine disrupting chemicals (EDCs) like polycyclic aromatic hydrocarbons, 
phthalates, benzophenones, parabens, and siloxanes. Routes of exposure are inhalation, 
dermal absorption, and ingestion. Occupational exposure to mineral and biological dusts, 
and gases and fumes occurs in manufacturing, construction, cleaning, food processing, 
and agriculture. Women can be exposed to solvents when working in healthcare, in beauty 
or hairdressing salons, or in cleaning occupations. Pesticides are commonly used among 
farmers and other agricultural workers. Most women occupationally exposed to metals 
are working in assembly of electronic equipment or mechanical machinery.
As embryo development and organogenesis takes place in utero in the first trimester, it is 
important to assess maternal occupational exposure during the periconceptional period. 
Men can be exposed to the same agents as women during their work, and previous 
studies suggest that paternal occupational exposure to chemicals can increase the risk 
of congenital anomalies such as neural tube defects, congenital heart defects, and 
hypospadias 30-33. However, paternal occupational exposure can affect spermatogenesis 
before conception, while maternal occupational exposure can affect the oocyte before 
conception as well as the embryo directly during foetal development. This thesis therefore 
focuses only on maternal occupational exposure.
AIMS
Since more and more women are participating in the labour force and the etiological 
processes of many congenital anomalies are not yet understood, it is important to identify 
occupational risk factors in order to protect women who want to become pregnant or 
are pregnant and their offspring. Particularly because being pregnant with or having an 
infant with a congenital anomaly has a large impact on infant mortality and morbidity, 
families, and society. Therefore, the aim of this thesis is to examine the association between 
maternal occupational exposures during the periconceptional period and congenital 
anomalies in the offspring. First, an overview of the literature will be presented (Chapter 
2). In the next chapters, maternal occupational exposure in relation to specific congenital 
anomalies is studied (Chapters 3-6). The specific congenital anomalies examined, study 
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populations, and exposure assessment methods used in this thesis are described in the 
following paragraphs.
Congenital anomalies studied in this thesis
Five subgroups of congenital anomalies are examined in this thesis (Figure 2). These are 
common congenital anomalies, and it is possible that occupational exposure can influence 
their development because these anomalies are of heterogenic origin.
Figure 2 | Prevalence of congenital anomalies (genetic origin and non-genetic origin) in Europe in 2011-2017 
(per 10,000 births) 13
Neural tube defects
Neural tube defects are defects of the central nervous system that develop when the 
neural tube fails to close during the third and fourth week after conception. Examples of 
neural tube defects are anencephaly, which is not compatible with life, and spina bifida, 
which introduces several developmental and neurological problems depending on the 
site and type of the defect. In Europe, 10 per 10,000 births are affected by a neural tube 
defect (Figure 2). Many factors are involved in the abnormal closure of the neural tube 
(e.g. folic acid usage) 34. Several studies have assessed the association between maternal 
occupational exposures and neural tube defects in offspring, but no clear conclusion 
could be drawn regarding the effect of occupational exposures on development of neural 
tube defects.
Congenital heart defects
Congenital heart defects are the most common congenital anomalies. In Europe, 79 
infants and foetuses per 10,000 births are affected (Figure 2). Subgroups of congenital 
heart defects are anatomically, clinically, epidemiologically, and developmentally 




heterogeneous. Examples of congenital heart defect subgroups are conotruncal defects, 
left or right ventricular outflow tract defects, and septal defects. It is important to assess 
the subgroups of congenital heart defects because these defects might differ in aetiology. 
Previous studies have suggested associations between maternal occupational exposure 
to solvents or pesticides and specific congenital heart defects 35,36. However, for most 
studies it has not been possible to assess the association between maternal occupational 
exposure and subgroups of congenital heart defects because most studies have only 
included a small number of cases.
Orofacial clefts
Orofacial clefts are malformations that result from failure of fusion of the lip and/or palate. 
The European prevalence of orofacial clefts is 14 per 10,000 births (Figure 2). The aetiology 
of orofacial clefts is not fully understood. It is known that the aetiology of the two subtypes 
of orofacial clefts, cleft lip with or without cleft palate and cleft palate, are different. Several 
studies have suggested that maternal occupational exposure to solvents or pesticides can 
increase the risk of orofacial clefts in offspring 37-43, and one study suggested an association 
between exposure to metals and orofacial clefts 44.
Urogenital defects
Urogenital anomalies are congenital anomalies representing any defect in the organs 
and tissues responsible for the formation and excretion of urine. Anomalies can be 
malformations of the renal parenchyma, anomalies of the urinary collecting system, 
abnormal embryonic migration of kidneys, or hypospadias. In hypospadias, the most 
common genital anomaly, the urethral opening is located at the ventral side of the penis. 
The prevalence of kidney and urinary collecting system anomalies in Europe is 35 per 
10,000 births, whereas 18 per 10,000 births are affected by hypospadias (Figure 2). It has 
been hypothesised that exposure to EDCs could influence the hormonal activity and 
adversely affect foetal development of the urogenital tract 45. Several studies have reported 
associations between maternal occupational exposure to EDCs and hypospadias 46-49. 
Studies regarding occupational exposure in relation to urinary anomalies are scarce.
Gastroschisis
Gastroschisis is a severe anomaly of the abdominal wall that involves a full-thickness 
para-umbilical defect through which intestines and other organs may herniate without a 
covering membrane. Approximately 4.5 per 10,000 births are affected by a gastroschisis 
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in the United States 50, compared to 2.5 per 10,000 births in Europe (Figure 2). It has been 
hypothesized that gastroschisis develops due to rupture or non-closure of the membrane 
covering the umbilical ring between 8 and 11 weeks after fertilization 51,52. Only one study 
has reported an association between maternal occupational exposure to solvents and 
gastroschisis 53.
Study populations
In this thesis, the association between maternal occupational exposure and congenital 
anomalies in offspring has been explored by conducting several case–control studies. 
Three different data sources have been used for these studies: Eurocat NNL and Lifelines 
from the Netherlands and the National Birth Defects Prevention Study (NBDPS) from the 
United States.
Eurocat NNL
The European Concerted Action on Congenital Anomalies and Twins Northern Netherlands 
(Eurocat NNL) is a population-based registry of congenital anomalies 54. This registry was 
founded in 1981 as part of a European network of congenital anomaly registries. The 
Eurocat NNL registry currently monitors about 16,000 births annually in the northern Dutch 
provinces of Groningen, Friesland and Drenthe. In addition to live births (up to 10 years 
of age at notification), Eurocat NNL also registers stillbirths, miscarriages, and pregnancies 
terminated because of congenital anomalies. These cases are reported by midwives, 
child healthcare physicians, and medical specialists. Additionally, sources are actively 
sought by registry workers to find children or pregnancies eligible for registration. The 
Eurocat NNL database contains detailed and high-quality information on approximately 
18,000 children or foetuses with congenital anomalies. Detailed medical information is 
available for each case, and all cases were coded by trained registry staff according to 
international coding guidelines 55. Since 1997, parents have also been asked to complete 
a questionnaire. Information is collected regarding the pregnancy, obstetric and medical 
history, demographic characteristics, use of medication, and occupation and lifestyle 
during the periconceptional period. Data from Eurocat NNL is used in Chapters 3-5.
Lifelines
Lifelines is a three-generation prospective cohort study that is following 167,000 
participants over a 30-year period in the same Northern Dutch region as Eurocat NNL 
56. The aim of Lifelines is to obtain insight into healthy ageing. Participants were invited 




through their general practitioners. Lifelines participants (between 18 and 65 years old) 
were asked to invite their offspring and parents to create a three-generation cohort. Their 
children could participate if they were between 6 months and 18 years old. We selected 
infants without a congenital anomaly from the Lifelines cohort as controls for the studies 
in Chapters 4 and 5. Parents of participating children completed a questionnaire regarding 
the pregnancy, their health, occupation, and lifestyle during pregnancy, childbirth, and 
health of their child in the first six months of life.
National Birth Defects Prevention Study
The National Birth Defects Prevention Study (NBDPS) is a large population-based 
multicentre case–control study of major structural congenital anomalies in the United 
States 57. Pregnancies with estimated delivery dates between 1997 and 2011 from ten 
states were included. All states included live-born cases, and most states also included 
cases of stillbirths and terminated pregnancies with a prenatal diagnosis of congenital 
anomalies. Cases were ascertained by the participating states’ congenital anomalies 
surveillance systems up to two years after delivery. Clinical information extracted from 
medical records was reviewed by a clinical geneticist at each centre using a systematic 
study-wide classification protocol to confirm eligibility. Controls were live-born infants 
without major congenital anomalies selected randomly from either vital records or hospital 
birth records from the same geographical region and time period as cases. Women who 
participated in the NBDPS completed a computer-assisted telephone interview. During this 
interview, mothers were asked to report information about demographics, medication use, 
occupational history, and their lifestyle during pregnancy and the three months preceding 
pregnancy. Data from the NBDPS is used in Chapters 6.
Occupational exposure assessment
Different methods have been developed to assess occupational exposures in 
epidemiological studies 58. In this thesis, two occupational exposure assessment methods 
have been used: job-exposure matrices (JEMs) and individual expert-based assessments by 
occupational hygienists. When using a JEM, descriptions of jobs held early in pregnancy 
are coded using the International Standard Classification of Occupations 1988 (ISCO88) 59. 
These job codes are then translated into occupational exposure using a JEM designed by 
occupational hygienists. In Chapters 3 and 5, the ALOHA+ JEM was used to assess exposure 
to organic and mineral dusts, solvents, pesticides, metals, and gases and fumes 60,61. In 
Chapter 4, a JEM assessing occupational exposure to chemicals known for their endocrine-
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disrupting effect was used 62,63. In Chapter 6, individual expert-based assessments by 
occupational hygienists were performed. Occupational experts can perform occupational 
exposure assessment for a variety of occupational exposures based on occupational 
histories that include job title, employer name, what the company makes or does, primary 
tasks and duties, a description of chemicals and machines handled on the job, dates of 
employment, and hours and days worked per week 64.
Both methods involve occupational hygienists, who by training have an understanding 
of exposure sources and pathways leading to occupational exposure, and both methods 
reduce the risk of recall bias and misclassification compared to the traditional method of 
using self-reported exposure in case–control studies 29,65. The JEM approach is less time-
consuming and cheaper, but assigns exposure at job level and by definition will not be 
able to make a distinction between the exposures of two women reporting the same job. 
This would be feasible with an individual-based expert assessment, but might result in 
differential misclassification given that it is based on self-reporting of tasks and duties and 
chemicals used. Comparisons of both methods in a multi-centre study demonstrated little 
advantage of individual exposure assessment when compared to a JEM 66.
Measuring occupational exposures directly is almost never feasible because measurements 
would have to be performed prospectively during the periconceptional period. 
This is almost impossible since most congenital anomalies are discovered after the 
periconceptional period, and prevalence of congenital anomalies is low. Biomonitoring 
of chemicals with a long half-life in cord blood would be a possibility, but again a large 
number of infants with congenital anomalies has to be included.




OUTLINE OF THIS THESIS
Chapter 2 provides an overview of the literature on the effects of maternal occupational 
exposure to solvents, pesticides and metals on several anomalies in offspring including 
neural tube defects, congenital heart defects, orofacial clefts, and hypospadias.
In Chapter 3, the association between maternal periconceptional occupational exposure 
and orofacial clefts in offspring is examined using a JEM and data from the Eurocat NNL 
registry.
In Chapter 4, the association between maternal occupational exposure early in pregnancy 
and urogenital anomalies in offspring is assessed using a JEM and data from Eurocat NNL 
and Lifelines.
In Chapter 5, the effect of maternal occupational exposure early in pregnancy on congenital 
heart defects in offspring is studied using a JEM and data from Eurocat NNL and Lifelines.
In Chapter 6, the effect of maternal occupational exposure to solvents on gastroschisis in 
offspring is examined using industrial hygienists and data from the NBDPS, United States.
In Chapter 7, the results of this thesis are summarised and discussed, and implications for 
further research and preventive policies are presented.
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